Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-27

Clinical Trial Update: Repeated Ketamine Infusions for Comorbid PTSD and MDD in Veterans [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating repeated ketamine infusions for veterans with co-occurring Post-Traumatic Stress Disorder and Major Depressive Disorder has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: University of Minnesota | Conditions: Post-Traumatic Stress Disorders, Major Depressive Disorder | Phase 1 | Status: COMPLETED